As of April 16, 2025, Genfit (GNFT) has a market cap of $0.18 billion USD. According to our data, Genfit is ranked No.7064 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.18 B |
-0.81%
|
Dec 31, 2024 | $0.19 B |
-3.51%
|
Dec 29, 2023 | $0.19 B |
-12.28%
|
Dec 30, 2022 | $0.22 B |
-12.22%
|
Dec 31, 2021 | $0.25 B |
4.17%
|
Dec 31, 2020 | $0.24 B |
-75.88%
|
Dec 31, 2019 | $0.99 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Madrigal Pharmaceuticals
MDGL
|
$7.09 B |
-0.000 M
|
![]() USA
|
![]() Viking Therapeutics
VKTX
|
$2.59 B |
-0.000 M
|
![]() USA
|
![]() Galmed Pharmaceuticals
GLMD
|
$3.18 M |
0.000 M
|
![]() Israel
|
![]() Akero Therapeutics
AKRO
|
$3.03 B |
0.000 M
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Enanta Pharmaceuticals
ENTA
|
$0.11 B |
-0.000 M
|
![]() USA
|
![]() 89bio
ETNB
|
$0.88 B |
-0.000 M
|
![]() USA
|
![]() Terns Pharmaceuticals
TERN
|
$0.21 B |
0.000 M
|
![]() USA
|
![]() Hepion Pharmaceuticals
HEPA
|
$3.84 M |
3.463 M
|
![]() USA
|
Market Cap | = | GNFT Stock Price | * | GNFT Shares Outstanding |
= | $3.68 | * | 49.91 M | |
= | $0.18 B |